Results 1 to 10 of about 21,501 (259)

Histopathologic Features of Maculopapular Drug Eruption

Dermatopathology, 2022
Background: Cutaneous adverse drug reaction (CADR) is common in both inpatient and outpatient clinical settings and has been associated with a large variety of medications.
Madison Ernst, Alessio Giubellino
doaj   +3 more sources

A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption

Medicina, 2021
Fixed drug eruption (FDE) is a cutaneous adverse drug reaction characterized by the onset of rash at a fixed location on the body each time a specific medication is ingested. With each recurrence, the eruption can involve additional sites.
Hannah J. Anderson, Jason B. Lee
doaj   +3 more sources

Risk of drug eruption associated with the use of tetracyclines, macrolides, and fluoroquinolones: real-world evidence from a pharmacovigilance study utilizing the FDA adverse event reporting system [PDF]

Saudi Pharmaceutical Journal
Recently, concerns regarding the risk of drug eruption associated with the use of tetracyclines were raised by the United States Food and Drug Administration (U.S. FDA). Therefore, it is necessary to reevaluate this risk. This study aimed to quantify the
Thamir M. Alshammari
doaj   +2 more sources

Wine-induced fixed drug eruption [PDF]

JAAD Case Reports
Jason Chen, BS, Melissa Willis, MD, Vincent Liu, MD   +2 more
doaj   +2 more sources

Clinical Profile of Cutaneous Adverse Drug Reactions in HIV Patients: A Cross-sectional Study [PDF]

Journal of Clinical and Diagnostic Research, 2023
Introduction: Cutaneous Adverse Drug Reaction (cADR) is one of the most common clinical presentation in patients with Acquired Immunodeficiency Syndrome (AIDS).
Seethalakshmi Ganga Vellaisamy, Minushwetha Masilamani, Divyasri Thangamuthu, Kannan Gopalan, N Kumarasamy   +4 more
doaj   +1 more source

Ustekinumab-induced fixed drug eruption

JAAD Case Reports, 2020
Dhafer M. Hafez, MD, Njood Alshehri, MD, Hamza Alshehri, MD, Najla A. Al-Dawsari, MD, FAAD   +3 more
doaj   +3 more sources

Drug eruption caused by ziprasidone： a case report

Sichuan jingshen weisheng, 2022
This paper reported a case of drug eruption in a male patient with first-episode schizophrenia. The patient received ziprasidone monotherapy， and experienced post-treatment remission of schizophrenic symptoms， while accompanied by drug eruption with ...
Hong Jiakun, Sun Yanbing, Liu Xiaobing
doaj   +1 more source

Two cases of childhood absence epilepsy who showed seizure disappearance after ethosuximide drug eruption

Acta Epileptologica, 2022
Background Recent studies suggest potential roles of immune response in the pathophysiology of epilepsy. Anti-seizure medications (ASMs) are known to have side effects of drug eruption caused by immune responses. A few reports in adults have demonstrated
Takuji Nakamura, Keiko Uda, Muneaki Matsuo, Masafumi Zaitsu   +3 more
doaj   +1 more source

Semaglutide-induced fixed drug eruption [PDF]

JAAD Case Reports
Sahithi Talasila, BS, Shayan Waseh, MD, MPH, Jeffrey Y. Liu, MD, Ibrahim Khalifeh, MD, Afton R. Metkowski, MD, Sylvia Hsu, MD   +5 more
doaj   +2 more sources

New insight into the causal relationship between Graves’ disease liability and drug eruption: a Mendelian randomization study

Frontiers in Immunology, 2023
BackgroundGraves’ disease (GD) and drug eruption are closely associated and frequently observed in the clinical setting. However, it remains unclear whether a causal relationship exists between these two conditions. The aim of the study is to investigate
Dide Wu, Boyuan Liu, Wei Xian, Yuxin Yang, Jinjian Li, Shubin Hong, Yanbing Li, Haipeng Xiao   +7 more
doaj   +1 more source